[go: up one dir, main page]

CA2223246A1 - Cell line producing analgesic compounds for treating pain - Google Patents

Cell line producing analgesic compounds for treating pain Download PDF

Info

Publication number
CA2223246A1
CA2223246A1 CA002223246A CA2223246A CA2223246A1 CA 2223246 A1 CA2223246 A1 CA 2223246A1 CA 002223246 A CA002223246 A CA 002223246A CA 2223246 A CA2223246 A CA 2223246A CA 2223246 A1 CA2223246 A1 CA 2223246A1
Authority
CA
Canada
Prior art keywords
cell
cells
ires
enkephalin
dna encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002223246A
Other languages
English (en)
French (fr)
Inventor
Shou Wong
Joel Saydoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbot Medical Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2223246A1 publication Critical patent/CA2223246A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002223246A 1995-06-07 1996-06-07 Cell line producing analgesic compounds for treating pain Abandoned CA2223246A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48191795A 1995-06-07 1995-06-07
US08/481,917 1995-06-07

Publications (1)

Publication Number Publication Date
CA2223246A1 true CA2223246A1 (en) 1996-12-19

Family

ID=23913905

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002223246A Abandoned CA2223246A1 (en) 1995-06-07 1996-06-07 Cell line producing analgesic compounds for treating pain

Country Status (20)

Country Link
EP (1) EP0833935A1 (cs)
JP (1) JPH11507530A (cs)
KR (1) KR19990022414A (cs)
CN (1) CN1192246A (cs)
AR (1) AR004494A1 (cs)
AU (1) AU6263696A (cs)
BR (1) BR9608746A (cs)
CA (1) CA2223246A1 (cs)
CZ (1) CZ392497A3 (cs)
EE (1) EE9700326A (cs)
HU (1) HUP9901191A2 (cs)
IL (1) IL122415A0 (cs)
IN (1) IN181898B (cs)
IS (1) IS4628A (cs)
NO (1) NO975545L (cs)
PL (1) PL323867A1 (cs)
SK (1) SK167997A3 (cs)
TR (1) TR199701520T1 (cs)
WO (1) WO1996040959A1 (cs)
ZA (1) ZA964880B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001525168A (ja) * 1997-11-28 2001-12-11 メディカル リサーチ カウンシル ベクター
AU6151899A (en) * 1998-09-23 2000-04-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods of treating chronic pain
WO2000024895A2 (en) * 1998-10-27 2000-05-04 Anticancer, Inc. Method and model for hair pigmentation
US6372489B1 (en) 1998-10-27 2002-04-16 Anticancer, Inc. Method and model for hair pigmentation
US6903244B1 (en) 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
AU2002952993A0 (en) 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
CA2551189A1 (en) 2003-12-24 2005-07-07 The Walter And Eliza Hall Institute Of Medical Research Therapeutic agents and uses therefor
EP1766389A4 (en) 2004-05-12 2008-08-27 Inst Medical W & E Hall METHOD OF ISOLATING CELLS
EP2407484B1 (en) 2005-06-24 2016-06-22 The Walter And Eliza Hall Institute Of Medical Research Therapeutic pro-apoptotic BH3-like molecules and methods for generating and/or selecting the same
WO2008011006A2 (en) 2006-07-18 2008-01-24 University Of Utah Research Foundation Methods for treating pain and screening analgesic compounds
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
KR20160019469A (ko) 2013-05-31 2016-02-19 더 유니버시티 오브 유타 리서치 파운데이션 코노톡신 펩티드, 제약 조성물 및 그의 용도
EP3368551B1 (en) 2015-10-27 2023-07-12 The University Of Queensland A modified epha4 polypeptide
CN107964047B (zh) * 2017-12-18 2018-11-02 哈尔滨工业大学 基于内吗啡肽-1和神经降压素(8-13)的嵌合肽及其合成方法和应用
CN112891337A (zh) * 2021-03-26 2021-06-04 河北医科大学 高良姜素及其衍生物在制备预防和治疗神经系统疾病药物中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0802800B1 (en) * 1993-08-12 2002-06-12 Neurotech S.A. Biocompatible immunoisolatory capsules containing genetically altered cells for the delivery of biologically active molecules

Also Published As

Publication number Publication date
JPH11507530A (ja) 1999-07-06
NO975545L (no) 1998-02-04
KR19990022414A (ko) 1999-03-25
NO975545D0 (no) 1997-12-02
IN181898B (cs) 1998-10-24
IL122415A0 (en) 1998-06-15
CZ392497A3 (cs) 1998-12-16
AU6263696A (en) 1996-12-30
HUP9901191A2 (hu) 1999-08-30
PL323867A1 (en) 1998-04-27
BR9608746A (pt) 1999-05-11
CN1192246A (zh) 1998-09-02
EE9700326A (et) 1998-06-15
IS4628A (is) 1997-12-04
ZA964880B (en) 1997-01-07
SK167997A3 (en) 1998-05-06
AR004494A1 (es) 1998-12-16
EP0833935A1 (en) 1998-04-08
TR199701520T1 (xx) 1998-04-21
WO1996040959A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
CA2223246A1 (en) Cell line producing analgesic compounds for treating pain
US6048724A (en) Method of producing clonal cell strains which express exogenous DNA encoding glucagon-like peptide 1
US5645829A (en) Mesothelial cell gene therapy
US6670178B1 (en) In Vivo production and delivery of insulinotropin for gene therapy
Panté et al. Exploring nuclear pore complex structure and function in molecular detail
US6579692B1 (en) Method of screening apoptosis inducing substances
JP2002528078A (ja) 細胞表面分子誘導性マクロファージ活性化
EP0494175A1 (en) Compositions for cell adhesion inhibition and methods of use
US5723333A (en) Human pancreatic cell lines: developments and uses
WO2000055181A1 (en) Methods of modulating cell attachment and migration
WO1999000146A1 (en) Development and use of human pancreatic cell lines
Mellon et al. Immortalized hypothalamic gonadotropin‐releasing hormone neurons
EP0808364B1 (en) Human pancreatic cell lines: developments and uses
WO2005019471A2 (en) Periostin-like factor: compositions and methods for making and using the same
AU1005400A (en) Pain cell line
US7919080B2 (en) Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity
US20050239094A1 (en) Compositions and methods for inducing and regulating bone formation
US6531124B1 (en) In vivo production and delivery of insulinotropin for gene therapy
US7125715B2 (en) Nucleic acid encoding a polypeptide promoting type II collagen formation and aggrecan production
JP2002523445A (ja) 脳腫瘍治療用のアルギネートカプセル
US20080241168A1 (en) Transmembrane protein amigo and uses thereof
Zhang The expression and distribution of neural cell adhesion and extracellular matrix molecules after injury to, and peripheral nerve grafting into, the adult mammalian CNS
Takeno et al. Effects of gastrin on the histamine‐secretory and proliferative activity of cultured carcinoid cells derived from the stomach of the rodent Mastomys natalensis
GoldsmithT et al. immortalized hypothalamic gonadotropin-releasing hormone
Kupershmidt et al. Modulation of Cardiac Na Current Phenotype by-Subunit Expression

Legal Events

Date Code Title Description
FZDE Discontinued